Drupal.behaviors.print = function(context) {window.print();window.close();}>
Tekmira Management Offers Pipeline Update, Reiterates Claim to Disputed Delivery Technology
March 29, 2012
Tekmira Management Offers Pipeline Update, Reiterates Claim to Disputed Delivery Technology
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
With Alnylam Settlement Money in Hand, Tekmira Plans 'Aggressive' Pipeline Advancement
November 15, 2012 / Gene Silencing News
Tekmira Releases Positive Interim Phase I Data on Cancer Drug, Unsure on Ebola Drug's Fate
August 16, 2012 / Gene Silencing News
Tekmira on Track to Move Cancer Drug into Phase II, Name New Clinical Candidate in ‘13
May 16, 2013 / Gene Silencing News
Tekmira to Present Cancer Drug Data at AACR, Aims for Phase II by Year-End
March 28, 2013 / Gene Silencing News
Oligo Drugs Advance in the Clinic in 2012 as Delivery Hurdles are Addressed
January 3, 2013 / Gene Silencing News